Sinopharm Group Co Ltd
HKEX:1099
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinopharm Group Co Ltd
HKEX:1099
|
CN |
|
G
|
Grupo Vasconia SAB
BMV:VASCONI
|
MX |
|
H
|
Hiroca Holdings Ltd
TWSE:1338
|
CN |
|
Hydro One Ltd
TSX:H
|
CA |
|
Jianmin Pharmaceutical Group Co Ltd
SSE:600976
|
CN |
Wall Street
Price Targets
Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Sinopharm Group Co Ltd
is 22.96 HKD
with a low forecast of 18.69 HKD and a high forecast of 26.99 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sinopharm Group Co Ltd's stock price target?
Price Target
22.96
HKD
According to Wall Street analysts, the average 1-year price target for
Sinopharm Group Co Ltd
is 22.96 HKD
with a low forecast of 18.69 HKD and a high forecast of 26.99 HKD.
What is Sinopharm Group Co Ltd's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Sinopharm Group Co Ltd's revenue is
13%.
The projected
CAGR
for the next 3 years is
5%.
What is Sinopharm Group Co Ltd's Operating Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Sinopharm Group Co Ltd's operating income is
11%.
The projected
CAGR
for the next 3 years is
26%.
What is Sinopharm Group Co Ltd's Net Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Sinopharm Group Co Ltd's net income is
11%.
The projected
CAGR
for the next 2 years is
12%.
